Innovus Pharma Selects Lebanese-Canadian Hospital for Its Post-Marketing Clinical Trials for CIRCUMserum™ and EjectDelay™

Published: Nov 11, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LA JOLLA, Calif., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") (OTCBB:INNV) today announced that the Company selected the Lebanese-Canadian Hospital in Beirut, Lebanon for its two post-marketing trials for CIRCUMserum™ to alleviate reduced penile sensitivity and EjectDelay™ for premature ejaculation.

Help employers find you! Check out all the jobs and post your resume.

Back to news